Refining the Sox10Dom/+ mouse model: A new breeding strategy with relevance to Hirschsprung disease genetics

Chaoting Lan , Jiazhang Chen , Shenwei Huang , Yide Mu , Qiuhua Wang , Xin Zhong , Ning Tang , Xinying Zhao , Jieting Lu , Yuxin Wu , Lihua Huang , Jixiao Zeng , Wei Zhong , Yu Ouyang , Qiuming He , Yan Zhang

Animal Models and Experimental Medicine ›› 2025, Vol. 8 ›› Issue (10) : 1866 -1875.

PDF
Animal Models and Experimental Medicine ›› 2025, Vol. 8 ›› Issue (10) :1866 -1875. DOI: 10.1002/ame2.70091
ORIGINAL ARTICLE
Refining the Sox10Dom/+ mouse model: A new breeding strategy with relevance to Hirschsprung disease genetics
Author information +
History +
PDF

Abstract

Background: The traditional Sox10Dom/+ mouse breeding strategy is costly and time-consuming, so this study aims to optimize the breeding method and improve the scientific research efficiency.

Methods: We select the offspring from mating B6C3Fe Sox10Dom/+ male mice with C57BL/6J female mice, and name the progeny B6C3Fe-g. Further, conduct separate self-breeding for both the B6C3Fe and B6C3Fe-g strains, adhering to the principle of pairing mutants with non-mutants. By comparing the number of offspring, survival rates, and the phenotype of aganglionosis in the colon, a comprehensive evaluation of their breeding capacity and phenotypic stability is conducted.

Results: Sanger sequencing results show that the mutation sites of B6C3Fe and B6C3Fe-g mice are consistent. After fluorescent staining of intestinal nerves, it was found that the heterozygous mice of the two strains had neuronal deletion in the distal colon, and this pathological phenotype was consistent with the pathological features of the diseased colon of Hirschsprung disease (HSCR). However, compared with the B6C3Fe strain, the B6C3Fe-g strain has a higher number of offspring and greater survival rates.

Conclusions: The breeding strategy of the B6C3Fe-g strain ensures genetic and phenotypic stability, while improving reproductive efficiency, and is an ideal scheme for breeding Sox10Dom/+ mice.

Keywords

B6C3Fe6 / B6C3Fe-g / Hirschsprung disease / Sox10

Cite this article

Download citation ▾
Chaoting Lan, Jiazhang Chen, Shenwei Huang, Yide Mu, Qiuhua Wang, Xin Zhong, Ning Tang, Xinying Zhao, Jieting Lu, Yuxin Wu, Lihua Huang, Jixiao Zeng, Wei Zhong, Yu Ouyang, Qiuming He, Yan Zhang. Refining the Sox10Dom/+ mouse model: A new breeding strategy with relevance to Hirschsprung disease genetics. Animal Models and Experimental Medicine, 2025, 8(10): 1866-1875 DOI:10.1002/ame2.70091

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Alves MM, Sribudiani Y, Brouwer RW, et al. Contribution of rare and common variants determine complex diseases—Hirschsprung disease as a model. Dev Biol. 2013;382(1):320-329.

[2]

Tomuschat C, Puri P. RET gene is a major risk factor for Hirschsprung's disease: a meta-analysis. Pediatr Surg Int. 2015;31(8):701-710.

[3]

Pingault V, Bondurand N, Kuhlbrodt K, et al. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet. 1998;18(2):171-173.

[4]

Zhang Y, Xie X, Zeng J, et al. Association of NRG1 and AUTS2 genetic polymorphisms with Hirschsprung disease in a south Chinese population. J Cell Mol Med. 2018;22(4):2190-2199.

[5]

Zhao J, Zhu Y, Xie X, et al. Pleiotropic effect of common PHOX2B variants in Hirschsprung disease and neuroblastoma. Aging (Albany NY). 2019;11(4):1252-1261.

[6]

Robinson NB, Krieger K, Khan FM, et al. The current state of animal models in research: a review. Int J Surg. 2019;72:9-13.

[7]

Lane PW, Liu HM. Association of megacolon with a new dominant spotting gene (Dom) in the mouse. J Hered. 1984;75(6):435-439.

[8]

Bondurand N, Sham MH. The role of SOX10 during enteric nervous system development. Dev Biol. 2013;382(1):330-343.

[9]

Wu J, Lu AD, Zhang LP, Zuo YX, Jia YP. Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi. 2019;40(1):52-57.

[10]

Pingault V, Zerad L, Bertani-Torres W, Bondurand N. SOX10: 20 years of phenotypic plurality and current understanding of its developmental function. J Med Genet. 2022;59(2):105-114.

[11]

Wang H, Liu M, Ye Z, et al. Akt regulates Sox10 expression to control oligodendrocyte differentiation via phosphorylating FoxO1. J Neurosci. 2021;41(39):8163-8180.

[12]

Lake JI, Heuckeroth RO. Enteric nervous system development: migration, differentiation, and disease. Am J Physiol Gastrointest Liver Physiol. 2013;305(1):G1-G24.

[13]

Angelozzi M, Lefebvre V. SOXopathies: growing family of developmental disorders due to SOX mutations. Trends Genet. 2019;35(9):658-671.

[14]

Gunadi, Amadeus VC, Utami FDT, et al. Aberrant SOX10 and RET expressions in patients with Hirschsprung disease. BMC Pediatr. 2024;24(1):189.

[15]

Pingault V, Ente D, Dastot-Le Moal F, Goossens M, Marlin S, Bondurand N. Review and update of mutations causing Waardenburg syndrome. Hum Mutat. 2010;31(4):391-406.

[16]

Lan C, Wu Y, Liu Y, et al. Establishment and identification of an animal model of Hirschsprung disease in suckling mice. Pediatr Res. 2023;94(6):1935-1941.

[17]

Gui H, Schriemer D, Cheng WW, et al. Whole exome sequencing coupled with unbiased functional analysis reveals new Hirschsprung disease genes. Genome Biol. 2017;18(1):48.

[18]

Rahman AA, Ohkura T, Bhave S, et al. Enteric neural stem cell transplant restores gut motility in mice with Hirschsprung disease. JCI Insight. 2024;9(17):e179755.

[19]

Montalva L, Cheng LS, Kapur R, et al. Hirschsprung disease. Nat Rev Dis Primers. 2023;9(1):54.

[20]

Tang CSM, Karim A, Zhong Y, Chung PHY, Tam PKH. Genetics of Hirschsprung's disease. Pediatr Surg Int. 2023;39(1):104.

[21]

Mahato AK, Sidorova YA. RET receptor tyrosine kinase: role in neurodegeneration, obesity, and cancer. Int J Mol Sci. 2020;21(19):7108.

[22]

Puffenberger EG, Hosoda K, Washington SS, et al. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell. 1994;79(7):1257-1266.

[23]

Rosenbaum SR, Tiago M, Caksa S, et al. SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects. Cell Rep. 2021;37(10):110085.

[24]

Drilon A, Hu ZI, Lai GGY, Tan DSW. Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes. Nat Rev Clin Oncol. 2018;15(3):151-167.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.

PDF

3

Accesses

0

Citation

Detail

Sections
Recommended

/